Isabl LinkedIn · Jan 2026
Isabl announced the pan-cancer study collaboration with Weill Cornell Medicine and emphasized that its WGS-based HRD classifier found HRD phenotypes beyond BRCA1/2 mutations.
Cancer tests based on whole genome and transcriptome data.
Company research
Public company, workplace, funding, and market signals
Overview
Isabl is a New York-based oncology diagnostics company building a whole-genome-and-transcriptome sequencing SaaS platform for cancer testing and biomarker discovery.
Primary product
Isabl GxT / WGTS SaaS platform
Founded
2020
Headquarters
New York, New York, United States
Team size
1-10
Work style
Remote
Industry
Medical and Diagnostic Laboratories
Sub-industry
oncology diagnostics / cancer genomics / molecular diagnostics
Offices
175 Greenwich Street, Floor 38, Manhattan, NY 10007
Open Positions
0 jobs at Isabl
No open positions
Check back later for new openings